We aim to identify promising startups and support them in their business development journey. With focus on startups in the seed to series A fund in the fields of healthcare, performance materials, life sciences, biotech, as well as other emerging technology fields, the 3-month China Accelerator Program in Shanghai will officially start in April 2019. The application platform is closed for the 1st intake, and all the applications are being evaluated at the current stage by around 170 internal experts from China and globally.
Get market access to expand your business building partner relationships, project opportunities and cooperate with external stakeholders.
Receive mentoring from Merck internal experts and external industry leaders.
Access to Merck China local network and multi-sites such as Guangzhou and Beijing with different business focus and ecosystems. In addition, you will be part of the most dynamic startup ecosystem in the world.
Benefit from tailored coaching sessions and workshops and innovate together with our dedicated project teams.
Gain exposure and visibility to investors and other business partners through participation on various events.
Receive funding up to €50,000 and the chance to get additional investment opportunities.
Access our global HQ innovation network
Selected startups will have the chance to join the Innovation Center in our headquarters in Germany for further project development. Additionally, you will have the chance to explore the European market.
The China innovation hub based in Shanghai combines unique technology and expertise from Merck and collaborators with the goal to develop novel technology and accelerate business growth in China as a strategic market.
As a world-class, innovative partner, it is committed to partnering with all parties, including startups, academic institutions, business partners and local governments, while nurturing employees, innovative mindsets and capabilities for win-win results. The Merck Innovation Hub in China scouts, accelerates and invests in new technologies and differentiated innovative solutions both within our existing business area, including Healthcare, Life Science, Performance Materials and other new innovation fields. It aims to bring new technologies and solutions to the market, help tackle China-specific challenges and support China’s transformation into an innovation-driven economy.